Speaker Profile
PhD, OBE, Director of QB3, UCSF
Biography
Dr. Regis B. Kelly is the Director of QB3, a renowned institute at UCSF that focuses on quantitatively analyzing biological systems. With a distinguished career in neurobiology, Dr. Kelly's research primarily revolved around the molecular mechanisms of neurotransmitter release, a fundamental process of the nervous system. He has held esteemed positions at UCSF, including serving as the Executive Vice Chancellor, and has been recognized with numerous awards for his contributions to science and education. Dr. Kelly's commitment to fostering innovation is evident in his role at QB3, where he supports entrepreneurs and helps translate academic research into realworld solutions. He earned his PhD from Caltech and has been a dedicated educator, mentoring the next generation of scientists and innovators.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Keith Yamamoto, UCSF
- PMWC 2024 Award Ceremony:
Luminary Honoree: Geoff Ginsburg, NIH (All of Us)
- Fireside Chat: Geoff Ginsburg, NIH and Keith Yamamoto, UCSF
- New Federal Programs Driving Transformative Health Breakthroughs (PANEL)
Chair: Keith Yamamoto, UCSF
- Arunan Skandarajah, ARPA-H
- Susan Marqusee, NSF
- Sheng Lin-Gibson, NIST - AI-driven Advances in Precision Medicine (PANEL)
Chair: Sharat Israni, Bakar Institute, UCSF
- Suzanne Tamang, Stanford
- Colleen Clancy, UC Davis
- Nevan Krogan, UCSF
- Lauren Erdman, University of Toronto - Precision Medicine in New Research Frameworks (PANEL)
Chair: Regis B. Kelly, UCSF
- Joe DeRisi, UCSF
- Luke Gilbert, UCSF
- Prachee Avasthi, Arcadia Science - Living Therapeutics for Precision Medicine
Chair: Michelle Hermiston, UCSF
- Peter Marks, FDA
- Wendell Lim, UCSF
- Liora Schultz, Stanford - AI and Precision Medicine: Navigating Equity and Social Justice Challenges (PANEL)
Chair: Hank Greely, Stanford
- Ziad Obermeyer, UC Berkeley
- Sara L. Ackerman, UCSF
